Last reviewed · How we verify

NCT04769323

Use of Virtual Reality Devices for Vestibular Rehabilitation

Completed NA Last updated 26 March 2025
What this trial tests

NA trial testing Virtual Reality in Virtual Reality in 41 participants. Completed in 15 June 2023.

Timeline
21 February 2021
Primary endpoint
15 June 2023
15 June 2023

Quick facts

Lead sponsorPamukkale University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment41
Start date21 February 2021
Primary completion15 June 2023
Estimated completion15 June 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Pamukkale University

Who can join

Adults 18 to 65, any sex, with Virtual Reality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the superiority of virtual reality-supported vestibular rehabilitation exercises over conventional vestibular rehabilitation exercises in patients with complaints such as vertigo, loss of balance, falling, and gait imbalance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual Reality

Trials testing the same drug.

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

Other Pamukkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04769323.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing